Muscarinic acetylcholine receptor expression in memory circuits: Implications for treatment of Alzheimer disease

AUTOR(ES)

Levey, Allan I.

FONTE

The National Academy of Sciences of the USA

RESUMO

Cholinergic transmission at muscarinic acetylcholine receptors (mAChR) has been implicated in higher brain functions such as learning and memory, and loss of synapses may contribute to the symptoms of Alzheimer disease. A heterogeneous family of five genetically distinct mAChR subtypes differentially modulate a variety of intracellular signaling systems as well as the processing of key molecules involved in the pathology of the disease. Although many muscarinic effects have been identified in memory circuits, including a diversity of pre- and post-synaptic actions in hippocampus, the identities of the molecular subtypes responsible for any given function remain elusive. All five mAChR genes are expressed in hippocampus, and subtype-specific antibodies have enabled identification, quantification, and localization of the encoded proteins. The m1, m2, and m4 mAChR proteins are most abundant in forebrain regions and they have distinct cellular and subcellular localizations suggestive of various pre- and postsynaptic functions in cholinergic circuits. The subtypes are also differentially altered in postmortem brain samples from Alzheimer disease cases. Further understanding of the molecular pharmacology of failing synapses in Alzheimer disease, together with the development of new subtype-selective drugs, may provide more specific and effective treatments for the disease.

Documentos Relacionados

• Memory: Recording experience in cells and circuits: Diversity in memory research
• Muscarinic receptor subtypes: implications for lung disease.
• Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia.
• Shifter circuits: a computational strategy for dynamic aspects of visual processing.
• Broncho-pulmonary Circuits: A Synoptic Appraisal 1